[PDF] Top 20 Las representaciones sociales del medio ambiente: el papel de la fotografía
Has 10000 "Las representaciones sociales del medio ambiente: el papel de la fotografía" found on our website. Below are the top 20 most common "Las representaciones sociales del medio ambiente: el papel de la fotografía".
New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
... of belinostat in the cited studies is in the range of that reported for romidepsin and pralatrexate, but the toxicity profiles of the three drugs ...addition, belinostat may be considered to serve as ... See full document
85
New developments in the treatment of osteoarthritis – focus on biologic agents
... to cell surface receptors and anabolic pathways activate, diminishing aggre- canase ...important role in tissue ...the new- est growth factors described recently by Kubota et al, 108 as ... See full document
17
New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
... additional treatment for PBC is clearly ...cytotoxic T-lymphocyte antigen 4 (abatacept) are currently under investigation for the treatment of ... See full document
11
An update on the management of peripheral T-cell lymphoma and emerging treatment options
... upfront treatment for most PTCL subtypes, excluding ALK-positive ALCL. The role of allogeneic stem cell transplantation is still under ...and new and more effective agents are desperately ... See full document
5
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
... HDACi are an innovative and emerging medication class gaining increased attention in the treatment of T-cell lymphomas. Medications in this drug class include romidepsin, vorinostat, panobinostat, ... See full document
89
New developments in the management of advanced melanoma – role of pembrolizumab
... programmed cell death-1 expressed by tumor-associated T-cells and its ligand programmed cell death-L1 present on tumor and stromal cells, was recently approved by US Food and Drug Administration for ... See full document
16
New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy
... included 322 patients randomized 2:1 to trametinib and the possibility of crossover from chemotherapy to trametinib at the time of progression. When considering the intention-to- treat population, progression-free ... See full document
16
BELINOSTAT: A HISTONE DEACETYLASE INHIBITOR FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA
... a new intravenous, once daily component of the hydroxamate category of HDAC was developed by Spectrum Pharmaceuticals for the treatment of relapsed or refractory peripheral T- cell ... See full document
9
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
... the role of a variety of agents in different classes such as immunomodulators, other HDACi, nucleoside analogs, monoclonal antibodies, or fusion proteins in relapsed ...of lymphoma while recommending ... See full document
19
New developments in the treatment of basal cell carcinoma: update on current and emerging treatment options with a focus on vismodegib
... vismo treatment for up to 36 ...vismo treatment led to a significant reduction in the appearance of new BCCs compared to ...tolerated treatment without a treatment break due to ...of ... See full document
6
New developments in the treatment of optic neuritis
... variable. New developments aimed at designing better treatments for patients who fail to recover are discussed, focusing on recent research elucidating mechanisms of damage and recovery in ...stem ... See full document
16
<p>Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis</p>
... The Robust Multi-array Average (RMA) algorithm in the affy Bioconductor package was utilized to analyze the raw data to construct the expression matrix pro fi le, 7 including background correction, quantile normalization, ... See full document
14
Peripheral T cell lymphoma: clinical utility of romidepsin
... tumor-derived cell lines by causing cell cycle arrest in various stages, ie, gap 1 (G1) or gap 2/mitosis (G2/M) phase with relative sparing of normal cells through deregulation of proteins that control ... See full document
22
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
... 97 patients with SqCC, median OS with atezolizumab was 10.1 months vs 8.6 months with docetaxel (HR 0.8, 95% CI 0.49–1.3; P = 0.04). In this study, OS was correlated with increasing levels of PDL1 expression (on both ... See full document
6
Therapeutic options in peripheral T cell lymphoma
... patients. Treatment con- sisted of gemcitabine at a dose of 1000 mg/m 2 intraven- ously on days 1 and 8, dexamethasone at a dose of 40 mg orally on days 1–4, and cisplatin 70 mg/m ... See full document
15
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
... with an exacerbation of latent tuberculosis. Infections or infestations (graded mild or moderate in around 99% in all groups) were reported in 47.7% of the patients in the cladribine 3.5-mg group, 48.9% of those in the ... See full document
14
Immunophenotyping of Nodal Peripheral T-cell Lymphomas and its Association with Epstein-Barr Virus
... null cell variant of ...null cell ALCL-ALK positive ...of T-cell markers could predict an advanced stage (stage IV disease), an attempt was made at statistical ...individual ... See full document
13
New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib
... (clear cell or non-clear cell ...(Sunitinib Treatment of Renal Adjuvant Cancer) trial is a two-armed trial comparing one year of sunitinib therapy versus placebo in patients with resected localized ... See full document
19
<p>Clinical features and prognostic factors of primary bone marrow lymphoma</p>
... successful treatment were found in our ...The treatment strate- gies and survival time of the T-cell lymphoma patients were ...initial treatment; the degree of cytopenia, serum ... See full document
74
Everolimus – a new approach in the treatment of renal cell carcinoma
... clear cell RCC were enrolled and divided into 2 groups: group A, no previous treatment with sorafenib or sunitinib; group B, previous treatment with sorafenib and/or ... See full document
96
Related subjects